Cerus (CERS) Competitors $1.65 -0.09 (-5.17%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.65 0.00 (-0.24%) As of 02/21/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CERS vs. STAA, OSUR, ANIK, UTMD, COO, WST, ALGN, MMSI, ICUI, and XRAYShould you be buying Cerus stock or one of its competitors? The main competitors of Cerus include STAAR Surgical (STAA), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), Utah Medical Products (UTMD), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry. Cerus vs. STAAR Surgical OraSure Technologies Anika Therapeutics Utah Medical Products Cooper Companies West Pharmaceutical Services Align Technology Merit Medical Systems ICU Medical DENTSPLY SIRONA Cerus (NASDAQ:CERS) and STAAR Surgical (NASDAQ:STAA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends, community ranking and profitability. Which has more volatility and risk, CERS or STAA? Cerus has a beta of 1.29, meaning that its share price is 29% more volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Does the MarketBeat Community believe in CERS or STAA? Cerus received 281 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 54.43% of users gave STAAR Surgical an outperform vote. CompanyUnderperformOutperformCerusOutperform Votes57072.34% Underperform Votes21827.66% STAAR SurgicalOutperform Votes28954.43% Underperform Votes24245.57% Do analysts rate CERS or STAA? Cerus presently has a consensus target price of $3.63, suggesting a potential upside of 119.70%. STAAR Surgical has a consensus target price of $26.86, suggesting a potential upside of 59.20%. Given Cerus' stronger consensus rating and higher possible upside, equities analysts clearly believe Cerus is more favorable than STAAR Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cerus 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75STAAR Surgical 1 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is CERS or STAA more profitable? STAAR Surgical has a net margin of -6.44% compared to Cerus' net margin of -11.60%. STAAR Surgical's return on equity of -3.35% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Cerus-11.60% -40.55% -11.12% STAAR Surgical -6.44%-3.35%-2.67% Which has higher valuation & earnings, CERS or STAA? STAAR Surgical has higher revenue and earnings than Cerus. STAAR Surgical is trading at a lower price-to-earnings ratio than Cerus, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCerus$180.27M1.70-$37.49M-$0.11-15.00STAAR Surgical$313.90M2.65-$20.21M-$0.41-41.15 Does the media favor CERS or STAA? In the previous week, Cerus had 7 more articles in the media than STAAR Surgical. MarketBeat recorded 15 mentions for Cerus and 8 mentions for STAAR Surgical. Cerus' average media sentiment score of 0.44 beat STAAR Surgical's score of 0.21 indicating that Cerus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cerus 2 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral STAAR Surgical 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in CERS or STAA? 78.4% of Cerus shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 3.4% of Cerus shares are held by company insiders. Comparatively, 1.0% of STAAR Surgical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryCerus beats STAAR Surgical on 11 of the 18 factors compared between the two stocks. Get Cerus News Delivered to You Automatically Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CERS vs. The Competition Export to ExcelMetricCerusSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$323.14M$4.71B$5.84B$9.14BDividend YieldN/A39.90%4.75%3.86%P/E Ratio-15.0030.1926.7919.19Price / Sales1.7055.31435.4570.88Price / CashN/A51.1038.0134.83Price / Book5.696.577.644.62Net Income-$37.49M$90.91M$3.19B$246.06M7 Day Performance-10.81%-2.39%-2.12%-2.63%1 Month Performance-8.84%-2.29%-0.45%-2.15%1 Year Performance-25.68%15.21%16.26%12.88% Cerus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CERSCerus2.8493 of 5 stars$1.65-5.2%$3.63+119.7%-26.3%$323.14M$180.27M-15.00290Earnings ReportAnalyst ForecastNews CoveragePositive NewsHigh Trading VolumeSTAASTAAR Surgical4.3506 of 5 stars$15.35-3.8%$26.86+75.0%-44.5%$756.45M$322.42M34.891,115High Trading VolumeOSUROraSure Technologies4.1043 of 5 stars$3.93+1.0%$5.50+39.9%-44.8%$293.14M$405.47M26.20840Analyst DowngradeANIKAnika Therapeutics2.8253 of 5 stars$17.86+1.2%$24.50+37.2%-29.3%$261.65M$166.66M-2.69300UTMDUtah Medical Products3.6007 of 5 stars$61.05-1.2%N/A-15.9%$206.96M$40.90M15.46180Positive NewsCOOCooper Companies2.6063 of 5 stars$88.10-6.0%$117.00+32.8%-9.8%$17.58B$3.90B45.1816,000High Trading VolumeWSTWest Pharmaceutical Services4.9605 of 5 stars$214.84+7.9%$344.00+60.1%-40.8%$15.56B$2.95B31.8710,600Dividend AnnouncementAnalyst DowngradeHigh Trading VolumeALGNAlign Technology4.7881 of 5 stars$206.77+0.9%$269.91+30.5%-37.5%$15.44B$4.00B36.8621,610MMSIMerit Medical Systems3.6376 of 5 stars$108.14-0.2%$109.80+1.5%+30.1%$6.30B$1.26B53.016,950Positive NewsICUIICU Medical4.6646 of 5 stars$160.16+1.2%$199.67+24.7%+51.1%$3.92B$2.26B-35.0514,000News CoverageXRAYDENTSPLY SIRONA4.8567 of 5 stars$18.32-2.4%$25.85+41.1%-43.3%$3.64B$3.97B-8.8515,000Analyst Upgrade Related Companies and Tools Related Companies STAA Competitors OSUR Competitors ANIK Competitors UTMD Competitors COO Competitors WST Competitors ALGN Competitors MMSI Competitors ICUI Competitors XRAY Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CERS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
